Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 25c, Beats on Revenue; Offers Guidance

Zimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $1.89, $0.25 better than the analyst estimate of $1.64. Revenue for the quarter came in at $1.83 billion versus the consensus estimate of $1.71 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2023 EPS of $7.40-$7.50, versus the consensus of $7.06.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance
• Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference